Povero M, Pradelli L, Serra A, Fanelli F, Gazzi L. Cost-Effectiveness Analysis of Alirocumab in High Cardiovascular-Risk Patients in Italy. FE [Internet]. 2021 Jun. 18 [cited 2025 Jul. 23];22(1). Available from: https://provafe.seedstm.com/index.php/FE/article/view/1499